A business in context

BDTX research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-23 · 8022 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-18 · 0002018686-26-000014

  2. 4 · Ownership change

    Report date 2026-09-18 · 0001193125-26-396868

  3. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001701541-26-000025

  4. 8-K · Current report

    Report date 2026-08-05 · 0001701541-26-000023 · Items 2.02,9.01

  5. 4 · Ownership change

    Report date 2026-06-26 · 0002018966-26-000007

  6. 4 · Ownership change

    Report date 2026-06-26 · 0002018686-26-000012

  7. 4 · Ownership change

    Report date 2026-06-26 · 0001682019-26-000002

  8. 4 · Ownership change

    Report date 2026-06-26 · 0001556064-26-000002

  9. 4 · Ownership change

    Report date 2026-06-26 · 0001456849-26-000002

  10. 4 · Ownership change

    Report date 2026-06-26 · 0001193125-26-288598

  11. 8-K · Current report

    Report date 2026-06-26 · 0001104659-26-078847 · Items 5.07

  12. 8-K · Current report

    Report date 2026-05-21 · 0001104659-26-065254 · Items 7.01,8.01,9.01

  13. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001701541-26-000017

  14. 8-K · Current report

    Report date 2026-05-07 · 0001701541-26-000015 · Items 2.02,9.01

  15. DEF 14A · Proxy statement

    Report date 2026-06-26 · 0001104659-26-051474

  16. 10-K · Annual report

    Report date 2025-12-31 · 0001701541-26-000009

  17. 8-K · Current report

    Report date 2026-03-16 · 0001701541-26-000008 · Items 2.02,9.01

  18. 8-K · Current report

    Report date 2025-12-03 · 0001104659-25-117975 · Items 2.02,7.01,8.01,9.01

  19. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001701541-25-000039

  20. 8-K · Current report

    Report date 2025-11-06 · 0001701541-25-000038 · Items 2.02,9.01

  21. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001701541-25-000030

  22. 8-K · Current report

    Report date 2025-08-07 · 0001701541-25-000029 · Items 2.02,9.01

  23. 8-K · Current report

    Report date 2025-06-12 · 0001104659-25-058893 · Items 5.07

  24. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001701541-25-000022

  25. 8-K · Current report

    Report date 2025-05-12 · 0001701541-25-000021 · Items 2.02,9.01

  26. DEF 14A · Proxy statement

    Report date 2025-06-12 · 0001104659-25-036339

  27. 8-K · Current report

    Report date 2025-03-18 · 0001104659-25-025338 · Items 1.01,7.01,9.01

  28. 10-K · Annual report

    Report date 2024-12-31 · 0001701541-25-000016

  29. 8-K · Current report

    Report date 2025-03-06 · 0001701541-25-000014 · Items 2.02,9.01

  30. SC 13G/A · Ownership disclosure

    0001897612-24-001981

  31. SC 13G · Ownership disclosure

    0000902664-24-006560

  32. SC 13G · Ownership disclosure

    0002012383-24-003406

  33. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001701541-24-000042

  34. 8-K · Current report

    Report date 2024-11-05 · 0001701541-24-000040 · Items 2.02,9.01

  35. SC 13G · Ownership disclosure

    0002012383-24-002128

  36. 8-K · Current report

    Report date 2024-10-07 · 0001104659-24-106676 · Items 5.02,7.01,8.01,9.01

  37. 8-K · Current report

    Report date 2024-09-23 · 0001104659-24-101874 · Items 7.01,8.01,9.01

  38. SC 13D/A · Ownership disclosure

    0001193125-24-197045

  39. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001701541-24-000030

  40. 8-K · Current report

    Report date 2024-08-06 · 0001701541-24-000028 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-23 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 2 transaction rows2AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

2 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-18
2026-09-21
Raman PrakashA · Grant / award
Acquired
Common Stock6801.01.93
2026-09-18
2026-09-21
Behbahani AliA · Grant / award
Acquired
Common Stock7707.01.93

Identity & relationships

Wikidata structured data · retrieved 2026-10-23 · 1658 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001701541Black Diamond Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-23 · 1197 checked identities; 0 unavailable records

Search names and former names
  • Aset Therapeutics, Inc. · former SEC name · 2017-03-28 to 2018-01-04

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$0$0

Bureau of Labor Statistics · retrieved 2026-10-23 · 9 selected series; gaps remain missing

Explore the CPI history ↗